SCHEMBL29317166

SCHEMBL29317166

CC(C)c1ccc2sc3cc(C(C)(C)C)ccc3c2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 2/20 0.33
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
SCN4A P35499 1/20 0.33
KIF11 P52732 4/20 0.32
PFKFB3 Q16875 6/20 0.32
PFKFB4 Q16877 3/20 0.32
PTPN7 P35236 1/20 0.31
DUSP3 P51452 1/20 0.31
PTPN12 Q05209 1/20 0.31
PTPN22 Q9Y2R2 1/20 0.31
ALDH1A1 P00352 3/20 0.31
HPGD P15428 2/20 0.31
APEX1 P27695 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24422194 0.94 RAB9A (0.36) RAB9ASMN1; SMN2NPC1PIM1PIM2
SCHEMBL19984033 0.92 NPC1 (0.39) RAB9ASMN1; SMN2NPC1SCN4AKIF11
SCHEMBL25887232 0.92 KIF11 (0.38) RAB9ASMN1; SMN2NPC1PIM1PIM2
SCHEMBL24604645 0.85 KIF11 (0.42) RAB9ASMN1; SMN2NPC1KIF11PTPN7
SCHEMBL23621474 0.83 GRIA4 (0.37)
SCHEMBL13522721 0.81 NPC1 (0.44) RAB9ASMN1; SMN2NPC1PIM1PIM2
SCHEMBL2706410 0.81 ALDH1A1 (0.43) RAB9ASMN1; SMN2NPC1KIF11ALDH1A1
SCHEMBL23421892 0.78 PTPN22 (0.49) RAB9ASMN1; SMN2PIM1PIM2KIF11
SCHEMBL12473850 0.77 KIF11 (0.47) RAB9ANPC1KIF11PTPN7DUSP3
SCHEMBL13084833 0.77 RAB9A (0.48) RAB9ASMN1; SMN2NPC1PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244961-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240244961-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS AOX1, AOC2, OSTC RAB9A 3418/4885SMN1; SMN2 3611/4885NPC1 1744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.